These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 9051151)

  • 21. Is a sampling transition zone important to increase the detection of prostate cancer in systematic prostatic biopsies?
    Queiroz MR; Falsarella PM; Moreira Valle LG; Cayres Mariotti G; Lemos GC; Alfer Junior W; Garcia RG
    Acta Radiol; 2021 Jun; 62(6):815-820. PubMed ID: 32631078
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Analysis of differences in clinicopathological features between prostate cancers located in the transition and peripheral zones.
    Sakai I; Harada K; Kurahashi T; Yamanaka K; Hara I; Miyake H
    Int J Urol; 2006 Apr; 13(4):368-72. PubMed ID: 16734852
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Impact of additional sampling in the TRUS-guided biopsy for the diagnosis of prostate cancer.
    Stamatiou K; Alevizos A; Karanasiou V; Mariolis A; Mihas C; Papathanasiou M; Bovis K; Sofras F
    Urol Int; 2007; 78(4):313-7. PubMed ID: 17495488
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Questionnaire based evaluation of prostate biopsy complication comparing different bioptic schemes].
    Damiano R; Oliva A; Cantiello F; Esposito C; Perdonà S; De Sio M; Bitonti M; Sacco R; D'Armiento M
    Arch Ital Urol Androl; 2003 Mar; 75(1):40-5. PubMed ID: 12741345
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prospective evaluation of a 21-sample needle biopsy procedure designed to improve the prostate cancer detection rate.
    de la Taille A; Antiphon P; Salomon L; Cherfan M; Porcher R; Hoznek A; Saint F; Vordos D; Cicco A; Yiou R; Zafrani ES; Chopin D; Abbou CC
    Urology; 2003 Jun; 61(6):1181-6. PubMed ID: 12809894
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Specificity and accuracy of TRUS-measured PSA-density and transition zone-PSA in the diagnosis of prostate cancer.
    Michielsen DP; De Boe VR; Braeckman JG; Keuppens FI
    Eur J Ultrasound; 1998 Nov; 8(2):125-8. PubMed ID: 9845794
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prostate cancer screening in the Tyrol, Austria: experience and results.
    Horninger W; Reissigl A; Rogatsch H; Volgger H; Studen M; Klocker H; Bartsch G
    Eur J Cancer; 2000 Jun; 36(10):1322-35. PubMed ID: 10882875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is extended 11-core biopsy valuable in benign prostatic hyperplasia patients with intermediate serum prostate-specific antigen (4.1-10 ng/ml) and prior negative sextant biopsy?
    Abdel-Khalek M; El-Baz M; Ibrahiem el-H
    Scand J Urol Nephrol; 2004; 38(4):315-20. PubMed ID: 15669591
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Follow-up of men with elevated prostate-specific antigen and one set of benign biopsies at prostate cancer screening.
    Zackrisson B; Aus G; Lilja H; Lodding P; Pihl CG; Hugosson J
    Eur Urol; 2003 Apr; 43(4):327-32. PubMed ID: 12667711
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate specific antigen density of the transition zone for early detection of prostate cancer.
    Djavan B; Zlotta AR; Byttebier G; Shariat S; Omar M; Schulman CC; Marberger M
    J Urol; 1998 Aug; 160(2):411-8; discussion 418-9. PubMed ID: 9679889
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Role of 3D-ultrasonography in the assessment of transitional zone PSA].
    Pierangeli T; Muraro GB
    Arch Ital Urol Androl; 2002 Dec; 74(4):282-4. PubMed ID: 12508752
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characteristics of screening detected prostate cancer in men 50 to 66 years old with 3 to 4 ng./ml. Prostate specific antigen.
    Lodding P; Aus G; Bergdahl S; Frösing R; Lilja H; Pihl CG; Hugosson J
    J Urol; 1998 Mar; 159(3):899-903. PubMed ID: 9474178
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transition zone biopsy in the detection of prostate cancer.
    Kojima Y; Nonomura N; Nose T; Inoue T; Tsuda K; Narumi Y; Nakamura H; Shin M; Yasunaga Y; Aozasa K; Miki T; Okuyama A
    Eur Urol; 2000 Jun; 37(6):675-9. PubMed ID: 10828667
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Value of systematic transition zone biopsy in the detection of prostate cancer.
    Maeda H; Ishitoya S; Aoki Y; Okubo K; Okada T; Maekawa S; Arai Y
    Int J Urol; 1997 Nov; 4(6):567-71. PubMed ID: 9477185
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combination and multivariate analysis of PSA-based parameters for prostate cancer prediction.
    Djavan B; Remzi M; Zlotta AR; Seitz C; Wolfram R; Hruby S; Bursa B; Schulman CC; Marberger M
    Tech Urol; 1999 Jun; 5(2):71-6. PubMed ID: 10458658
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prostate biopsy: who, how and when. An update.
    Djavan B; Milani S; Remzi M
    Can J Urol; 2005 Feb; 12 Suppl 1():44-8; discussion 99-100. PubMed ID: 15780165
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Total and transition zone prostate volume and age: how do they affect the utility of PSA-based diagnostic parameters for early prostate cancer detection?
    Djavan B; Zlotta AR; Remzi M; Ghawidel K; Bursa B; Hruby S; Wolfram R; Schulman CC; Marberger M
    Urology; 1999 Nov; 54(5):846-52. PubMed ID: 10565745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Relationship between screening by stratifying cases into groups on prostate specific antigen level and the positive rate of transrectal ultrasound guided systematic sextant prostate biopsy].
    Cao XL; Gao JP; Han G; Tang J; Hong BF
    Zhonghua Wai Ke Za Zhi; 2006 Mar; 44(6):372-5. PubMed ID: 16638344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Transrectal ultrasound-guided transperineal 14-core systematic biopsy detects apico-anterior cancer foci of T1c prostate cancer.
    Kawakami S; Kihara K; Fujii Y; Masuda H; Kobayashi T; Kageyama Y
    Int J Urol; 2004 Aug; 11(8):613-8. PubMed ID: 15285751
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clinicopathological study of prostate cancer patients who had a serum PSA level of more than 20 ng/ml and were treated by a radical prostatectomy].
    Udo K; Otsubo S; Sakamoto N; Iguchi A
    Nihon Hinyokika Gakkai Zasshi; 2007 Jul; 98(5):685-90. PubMed ID: 17682447
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.